Literature DB >> 12456802

Attenuation of glucocorticoid signaling through targeted degradation of p300 via the 26S proteasome pathway.

Qiao Li1, Anna Su, Jihong Chen, Yvonne A Lefebvre, Robert J G Haché.   

Abstract

The effects of acetylation on gene expression are complex, with changes in chromatin accessibility intermingled with direct effects on transcriptional regulators. For the nuclear receptors, both positive and negative effects of acetylation on specific gene transcription have been observed. We report that p300 and steroid receptor coactivator 1 interact transiently with the glucocorticoid receptor and that the acetyltransferase activity of p300 makes an important contribution to glucocorticoid receptor-mediated transcription. Treatment of cells with the deacetylase inhibitor, sodium butyrate, inhibited steroid-induced transcription and altered the transient association of glucocorticoid receptor with p300 and steroid receptor coactivator 1. Additionally, sustained sodium butyrate treatment induced the degradation of p300 through the 26S proteasome pathway. Treatment with the proteasome inhibitor MG132 restored both the level of p300 protein and the transcriptional response to steroid over 20 h of treatment. These results reveal new levels for the regulatory control of gene expression by acetylation and suggest feedback control on p300 activity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12456802     DOI: 10.1210/me.2002-0154

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  18 in total

Review 1.  Chemical biology of histone acetyltransferase natural compounds modulators.

Authors:  Fabrizio Dal Piaz; Antonio Vassallo; Osmany Cuesta Rubio; Sabrina Castellano; Gianluca Sbardella; Nunziatina De Tommasi
Journal:  Mol Divers       Date:  2011-01-01       Impact factor: 2.943

2.  Promoter context determines the role of proteasome in ligand-dependent occupancy of retinoic acid responsive elements.

Authors:  Aliaa Higazi; Mahmoud Abed; Jihong Chen; Qiao Li
Journal:  Epigenetics       Date:  2011-02-01       Impact factor: 4.528

3.  PML activates transcription by protecting HIPK2 and p300 from SCFFbx3-mediated degradation.

Authors:  Yutaka Shima; Takito Shima; Tomoki Chiba; Tatsuro Irimura; Pier Paolo Pandolfi; Issay Kitabayashi
Journal:  Mol Cell Biol       Date:  2008-09-22       Impact factor: 4.272

4.  TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.

Authors:  Karen Dendoncker; Steven Timmermans; Jolien Vandewalle; Melanie Eggermont; Joanna Lempiäinen; Ville Paakinaho; Evelien Van Hamme; Sylviane Dewaele; Sofie Vandevyver; Marlies Ballegeer; Jolien Souffriau; Lise Van Wyngene; Kelly Van Looveren; Tineke Vanderhaeghen; Rudi Beyaert; Karolien De Bosscher; Jorma J Palvimo; Marc Van Montagu; Claude Libert
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-10       Impact factor: 11.205

5.  B56 regulatory subunit of protein phosphatase 2A mediates valproic acid-induced p300 degradation.

Authors:  Jihong Chen; Jonathan R St-Germain; Qiao Li
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

6.  The F-box protein beta-TrCp1/Fbw1a interacts with p300 to enhance beta-catenin transcriptional activity.

Authors:  Erin A Kimbrel; Andrew L Kung
Journal:  J Biol Chem       Date:  2009-03-17       Impact factor: 5.157

7.  Involvement of GR and p300 in the induction of H6PD by cortisol in human amnion fibroblasts.

Authors:  Weihua Wang; Chunming Guo; Wenjiao Li; Jianneng Li; Wangsheng Wang; Leslie Myatt; Kang Sun
Journal:  Endocrinology       Date:  2012-11-02       Impact factor: 4.736

8.  BRMS1 suppresses lung cancer metastases through an E3 ligase function on histone acetyltransferase p300.

Authors:  Yuan Liu; Marty W Mayo; Alykhan S Nagji; Emily H Hall; Lisa S Shock; Aizhen Xiao; Edward B Stelow; David R Jones
Journal:  Cancer Res       Date:  2012-12-26       Impact factor: 12.701

9.  Catalytic activity of the proteasome fine-tunes Brg1-mediated chromatin remodeling to regulate the expression of inflammatory genes.

Authors:  Sarah J Cullen; Subramaniam Ponnappan; Usha Ponnappan
Journal:  Mol Immunol       Date:  2009-10-01       Impact factor: 4.407

10.  Combination of ursodeoxycholic acid and glucocorticoids upregulates the AE2 alternate promoter in human liver cells.

Authors:  Fabián Arenas; Isabel Hervias; Miriam Uriz; Ruth Joplin; Jesús Prieto; Juan F Medina
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.